Overview
Peptides are restricted, not freely legal, in Turkey. Turkey's national medicines regulator, the Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK, Turkish Medicines and Medical Devices Agency), requires any human medicinal product -- including peptide drugs -- to hold a marketing license under the Pharmaceuticals and Medical Preparations Law and the Licensing Regulation on Human Medicinal Products before it can be sold or imported, whether for personal use or otherwise. Licensed peptide hormones such as semaglutide (for diabetes) and somatropin are available strictly by prescription, whereas unlicensed research-chemical peptides fall outside any approved pathway and can only be treated as unauthorized drugs if imported or sold for human use. A separate TİTCK "Foreign Drug Supply" regulation allows a narrow, prescription-based, institutionally-controlled route for unlicensed-in-Turkey medicines needed for a diagnosed condition, but this is not a general personal-import allowance for research peptides.
Key Points
- Turkey's Pharmaceuticals and Medical Preparations Act and its Licensing Regulation on Human Medicinal Products prohibit placing any drug, including peptide-based drugs, on the Turkish market or importing it without a TİTCK license, and this prohibition applies whether the import is commercial or for personal use. [3]
- TİTCK is the Turkish national authority responsible for licensing human medicinal products and is the same agency listed as the national competent authority for controlled-substance travel documentation into Turkey. [5]
- Personal import of medication into Turkey by travelers is governed by Ministry of Customs and Trade Circular No. 2011/39, which conditions entry of medicine for personal treatment on presenting a prescription or medical report to customs stating the drug, dose, and duration of need. [4]
- Travelers carrying medicine into Turkey, including preparations with controlled or narcotic content, are expected to bring only the quantity needed to cover the duration of their stay or treatment, per the guidance submitted to the International Narcotics Control Board. [5]
- For a medicine not licensed or not marketed in Turkey, TİTCK's Foreign Drug Supply Regulation only allows procurement through the official İbn-i Sina Health Social Security Center pharmacy depot on a prescription basis, and Institution (TİTCK) approval must be obtained before the product can be used. [2]
- Everyone.org's guide to importing unapproved medicine into Turkey states that a doctor's report/prescription plus a special Ministry of Health import permit are required, and that the imported quantity must be limited to the treatment period needed. [6]
- Wegovy (semaglutide for chronic weight management) had not been granted TİTCK marketing approval as of the source's reporting, meaning it could not be lawfully prescribed or sold in Turkey under that brand/indication at that time. [7]
- No Turkey-specific enforcement action, court case, or gazette notice naming BPC-157, TB-500, or other named research peptides was found in this research; the restrictions described above stem from Turkey's general medicines-licensing framework rather than a peptide-specific statute. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)